DNTH
Dianthus Therapeutics Inc

1,236
Mkt Cap
$2.01B
Volume
104,910.00
52W High
$57.50
52W Low
$13.37
PE Ratio
-13.34
DNTH Fundamentals
Price
$48.78
Prev Close
$46.58
Open
$47.29
50D MA
$44.34
Beta
1.00
Avg. Volume
944,874.95
EPS (Annual)
-$2.55
P/B
3.65
Rev/Employee
$79,935.90
Loading...
Loading...
News
all
press releases
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Short Interest Update
Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totaling 7,378,003 shares, a...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Get Free Report) have received an average rating of "Moderate Buy" from the nine brokerages that are presently covering the stock, MarketBeat...
MarketBeat·6d ago
News Placeholder
Biotech Stocks To Follow Today - January 30th
Danaher, VivoSim Labs, Moderna, Vaxcyte, and Dianthus Therapeutics are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies...
MarketBeat·7d ago
News Placeholder
Dianthus Therapeutics (NASDAQ:DNTH) Sees Unusually-High Trading Volume - Here's Why
Dianthus Therapeutics (NASDAQ:DNTH) Sees Large Volume Increase - What's Next...
MarketBeat·7d ago
News Placeholder
Dianthus Therapeutics (NASDAQ:DNTH) Hits New 52-Week High - Should You Buy?
Dianthus Therapeutics (NASDAQ:DNTH) Sets New 52-Week High - Here's What Happened...
MarketBeat·8d ago
News Placeholder
Dianthus Therapeutics, Inc. (DNTH) Moves 9.9% Higher: Will This Strength Last?
Dianthus Therapeutics, Inc. (DNTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·14d ago
News Placeholder
Dianthus Therapeutics (NASDAQ:DNTH) Trading Up 10.3% - What's Next?
Dianthus Therapeutics (NASDAQ:DNTH) Trading Up 10.3% - Time to Buy...
MarketBeat·15d ago
News Placeholder
Dianthus Therapeutics (NASDAQ:DNTH) Sets New 12-Month High - Should You Buy?
Dianthus Therapeutics (NASDAQ:DNTH) Hits New 52-Week High - Here's What Happened...
MarketBeat·17d ago
News Placeholder
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Short Interest Up 47.4% in December
Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totaling 6,136,786 shares, an increase of...
MarketBeat·21d ago
News Placeholder
First Week of March 20th Options Trading For Dianthus Therapeutics (DNTH)
Investors in Dianthus Therapeutics Inc (Symbol: DNTH) saw new options begin trading this week, for the March 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down...
Nasdaq News: Markets·21d ago
<
1
2
...
>

Latest DNTH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.